Buying $100 In COR: If an investor had bought $100 of COR stock 5 years ago, it would be worth $257.27 today based on a price ...

Project GOLD is a first-of-its-kind resiliency collaboration in the U.S., uniquely designed to address drug shortages in the oncology sector. At launch, Project GOLD has already achieved three ...

Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. (COR) is a leading pharmaceutical services company dedicated to ...

Q1 2025 Management View CEO Robert Mauch highlighted strong Q1 performance with 13% revenue growth and a 14% increase in adjusted EPS. He attributed this success to robust execution in the U.S.

Additionally, Cencora takes legal ownership of its suppliers’ products and absorbs all inventory and credit risk associated with delinquent pharmacies, clinics, and providers. We expect the US ...

Shares of Cencora Inc. COR shed 1.12% to $251.57 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.72% to 6,037.88 and ...

Wells Fargo analyst Stephen Baxter raised the firm’s price target on Cencora (COR) to $251 from $237 and keeps an Equal Weight rating on the shares following new guidance. The firm notes Cencora ...

This is an increase from Cencora’s previous quarterly dividend ... supply management software to retail and institutional healthcare providers; packaging solutions to various institutional ...

Through this element of the program, it will enable retina providers to confidently use practices, such as IHEEZO and TRIESENCE, in their practices. “We are thrilled to collaborate with Cencora on the ...